Detalhe da pesquisa
1.
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.
Immunity
; 49(5): 958-970.e7, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446386
2.
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo.
Brain Behav Immun
; 118: 468-479, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503395
3.
Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms.
J Immunol
; 198(10): 3999-4011, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404636
4.
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.
J Clin Immunol
; 36 Suppl 1: 88-94, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922075
5.
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058324
6.
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
J Exp Clin Cancer Res
; 41(1): 131, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392965
7.
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.
Blood Adv
; 4(13): 2886-2898, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589730
8.
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Cancer Res
; 77(10): 2699-2711, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363997